Liberty Global Announces Record and Distribution Dates for Upcoming Split-Off of Latin American Division

Liberty Global plc (“Liberty Global”) (NASDAQ: LBTYA, LBTYB, LBTYK, LILA and LILAK) today announced that, in connection with the previously announced split-off of its subsidiary Liberty Latin America Ltd. (“Liberty Latin America”), which comprises Liberty Global’s operations in Latin America and the Caribbean that are currently attributed to its “LiLAC Group,” it has set a … Continue reading “Liberty Global Announces Record and Distribution Dates for Upcoming Split-Off of Latin American Division”

REPROS THERAPEUTICS INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Repros Therapeutics Inc. (“Repros” or the “Company”) (NASDAQ CM: RPRX) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Allergan plc (“Allergan”) (NYSE: AGN). Under the … Continue reading “REPROS THERAPEUTICS INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout”

AltaPacific Bancorp Extends Share Repurchase Program

AltaPacific Bancorp (OTCBB:ABNK), the parent company of AltaPacific Bank, today announced that its Board of Directors has authorized an extension of the Company’s share repurchase program for an additional $4.0 million of the Company’s common stock through December 31, 2019. The Company’s repurchase program was originally announced on May 4, 2012. Since that date, the Company … Continue reading “AltaPacific Bancorp Extends Share Repurchase Program”

Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma

Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that data from the Phase 3 ECHELON-1 clinical trial evaluating ADCETRIS (brentuximab vedotin) as part of a frontline combination chemotherapy regimen in untreated advanced classical Hodgkin lymphoma will be presented in the Plenary Scientific Session at the 59th American Society of Hematology (ASH) annual … Continue reading “Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma”

bluebird bio Announces Updated Clinical Results from Ongoing Phase 1 Multicenter Study of LentiGlobin™ Gene Therapy in Severe Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting

bluebird bio, Inc. (NASDAQ: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies for cancer, today announced that updated clinical results from HGB-206, the company’s ongoing Phase 1 multicenter study of its LentiGlobin gene therapy product candidate in patients with severe sickle cell disease (SCD), will … Continue reading “bluebird bio Announces Updated Clinical Results from Ongoing Phase 1 Multicenter Study of LentiGlobin™ Gene Therapy in Severe Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting”

Wells Fargo Announces Fourth Quarter 2017 Earnings Information

Wells Fargo & Company (NYSE: WFC), as previously announced, will report its fourth quarter 2017 earnings on Friday, January 12, 2018, at 5 a.m. PT (8 a.m. ET). The news release will be available at https://www.wellsfargo.com/about/investor-relations/quarterly-earnings/. The Company will host a live conference call on Friday, January 12, at 7 a.m. PT (10 a.m. ET). You … Continue reading “Wells Fargo Announces Fourth Quarter 2017 Earnings Information”

United Rentals Announces Extension of Exchange Offer for URNA’s 4.875% Senior Notes due 2028

United Rentals, Inc. (NYSE:URI) (“URI” or the “Company”) today announced that its subsidiary, United Rentals (North America), Inc. has extended the expiration date of its offer to exchange (the “Exchange Offer”) up to $750 million aggregate principal amount of its outstanding 4.875% Senior Notes due 2028 issued in a registered offering on September 22, 2017 (the “Old … Continue reading “United Rentals Announces Extension of Exchange Offer for URNA’s 4.875% Senior Notes due 2028”

Bragar Eagel & Squire, P.C. Is Investigating Eagle Bancorp, Inc. (EGBN) on Behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against Eagle Bancorp, Inc. (NASDAQ:EGBN). Our investigation concerns whether Eagle Bancorp has violated the federal securities laws and/or engaged in other unlawful business practices. On December 1, 2017, Aurelius value published an article purporting to have uncovered evidence of an insider loan scheme involving the CEO and … Continue reading “Bragar Eagel & Squire, P.C. Is Investigating Eagle Bancorp, Inc. (EGBN) on Behalf of Stockholders and Encourages Investors to Contact the Firm”

OneMain Holdings, Inc. (NYSE:OMF) (“OMH”) announced today that its indirect, wholly owned subsidiary Springleaf Finance Corporation (“SFC”) priced $875 million aggregate principal amount of 5.625% senior notes due March 2023 (the “notes”) in connection with its previously announced registered notes offering. The notes will be guaranteed on an unsecured basis by OMH (the “guarantee”). The size of … Continue reading “”

Time Warner Inc. Announces Cash Tender Offers and Consent Solicitations for Debt Securities

Time Warner Inc. (NYSE:TWX) today announced it has commenced cash tender offers to purchase the outstanding debt securities of Time Warner and Historic TW Inc. (“HTW”) (including in its capacity as successor by merger to Time Warner Companies, Inc. (“TWCI”)) set forth in the column entitled “Debentures” in the table below (collectively, the “Debentures”, and, each a … Continue reading “Time Warner Inc. Announces Cash Tender Offers and Consent Solicitations for Debt Securities”